Immunogen (IMGN) Tops Q2 EPS by 11c
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Price: $31.25 --0%
Financial Fact:
Other (expense) income, net: 129K
Today's EPS Names:
DTGI, CRMT, MAYS, More
Financial Fact:
Other (expense) income, net: 129K
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Immunogen (NASDAQ: IMGN) reported Q2 EPS of ($0.02), $0.11 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $77.4 million versus the consensus estimate of $49.15 million.
For earnings history and earnings-related data on Immunogen (IMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- BMO Capital on FedEx (FDX): 'Guidance Appears Consistent With Our Forecasts'
- Archrock names Mohit Singh as CFO, effective July 6
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
